Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Rawson · SciRah

Researcher profile · Semantic Scholar

R. Rawson

Share profile

R. Rawson — researcher profile on SciRah

h-index: 23
Works: 96
Citations: 3,005

Most-cited papers

Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma.
C. Blank, M. Lucas, R. Scolyer, B. A. van de Wiel +64 more
2024New England Journal of Medicine448 citations Open access
Semantic Scholar
Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial
I. Reijers, A. Menzies, A. V. van Akkooi, J. Versluis +34 more
2022Nature Medicine356 citations Open access
Semantic Scholar
Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets
F. Newell, Y. Kong, J. Wilmott, P. Johansson +40 more
2019Nature Communications289 citations Open access
Semantic Scholar
Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma
M. Tetzlaff, Jane L. Messina, J. Stein, Xiaowei Xu +19 more
2018Annals of Oncology275 citations Open access
Semantic Scholar
Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial.
G. Long, R. Saw, S. Lo, O. Nieweg +18 more
2019The Lancet Oncology169 citations
Semantic Scholar
Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity
F. Newell, J. Wilmott, P. Johansson, K. Nones +31 more
2020Nature Communications158 citations Open access
Semantic Scholar
Melanoma pathology reporting and staging
R. Scolyer, R. Rawson, J. Gershenwald, P. Ferguson +1 more
2019Modern Pathology102 citations Open access
Semantic Scholar
Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
F. Newell, P. Johansson, J. Wilmott, K. Nones +31 more
2022Cancer Discovery94 citations Open access
Semantic Scholar
PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors
H. Kakavand, R. Rawson, Gulietta M. Pupo, J. Yang +10 more
2017Clinical Cancer Research85 citations Open access
Semantic Scholar
IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma
I. Reijers, Disha Rao, J. Versluis, A. Menzies +22 more
2023Journal of Experimental Medicine78 citations Open access
Semantic Scholar
Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma
Georgina V. Long, E. Shklovskaya, L. Satgunaseelan, Yi-Zhe Mao +31 more
2025Nature Medicine77 citations Open access
Semantic Scholar
Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma.
R. Rawson, C. Adhikari, C. Bierman, S. Lo +26 more
2021Annals of Oncology62 citations Open access
Semantic Scholar
First safety and efficacy results of PRADO: A phase II study of personalized response-driven surgery and adjuvant therapy after neoadjuvant ipilimumab (IPI) and nivolumab (NIVO) in resectable stage III melanoma.
C. Blank, I. Reijers, T. Pennington, J. Versluis +16 more
202060 citations
Semantic Scholar
Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites
J. Conway, R. Rawson, S. Lo, T. Ahmed +14 more
2022Journal for ImmunoTherapy of Cancer57 citations Open access
Semantic Scholar
Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic value
R. Barnhill, Pieter-Jan van Dam, P. Vermeulen, G. Champenois +11 more
2020The Journal of Pathology: Clinical Research51 citations Open access
Semantic Scholar
Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma.
I. Reijers, R. Rawson, A. Colebatch, E. Rozeman +15 more
2022JAMA Surgery50 citations Open access
Semantic Scholar
The smart approach: feasibility of lentigo maligna superficial margin assessment with hand‐held reflectance confocal microscopy technology
G. Pellacani, N. De Carvalho, S. Ciardo, B. Ferrari +11 more
2018Journal of the European Academy of Dermatology and Venereology45 citations Open access
Semantic Scholar
Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas
Camelia Quek, R. Rawson, P. Ferguson, Ping Shang +9 more
2019OncoTarget43 citations Open access
Semantic Scholar
Unexpected UVR and non-UVR mutation burden in some acral and cutaneous melanomas
R. Rawson, P. Johansson, N. Hayward, N. Waddell +7 more
2017Laboratory Investigation41 citations Open access
Semantic Scholar
Histopathological features of complete pathological response predict recurrence-free survival following neoadjuvant targeted therapy for metastatic melanoma.
M. Tetzlaff, C. Adhikari, S. Lo, R. Rawson +17 more
2020Annals of Oncology36 citations Open access
Semantic Scholar
Clinicopathological characteristics and management of colitis with anti-PD1 immunotherapy alone or in combination with ipilimumab
K. Nahar, R. Rawson, T. Ahmed, S. Tattersall +8 more
2020Journal for ImmunoTherapy of Cancer36 citations Open access
Semantic Scholar
Diagnostic utility of PRAME, p53 and 5-hmC immunostaining for distinguishing melanomas from naevi, neurofibromas, scars and other histological mimics.
R. Rawson, Eva R. Shteinman, S. Ansar, Ismael A. Vergara +4 more
2022Pathology (Sydney)27 citations
Semantic Scholar
The prognostic significance of microsatellites in cutaneous melanoma
M. Niebling, L. Haydu, S. Lo, R. Rawson +5 more
2020Modern Pathology27 citations Open access
Semantic Scholar
Updated pan-tumor guidelines for neoadjuvant scoring of pathologic response: a joint SITC and INMC effort
J. S. Deutsch, R. Scolyer, E. Burton, K. Busam +19 more
2025Annals of Oncology21 citations
Semantic Scholar
Not all melanomas are created equal: a review and call for more research into nodular melanoma
C. Dessinioti, A. Geller, D. Whiteman, C. Garbe +7 more
2021British Journal of Dermatology21 citations
Semantic Scholar
Five-year analysis of neoadjuvant dabrafenib and trametinib for stage III melanoma.
A. Menzies, S. Lo, R. Saw, Maria Gonzalez +14 more
2024Annals of Oncology18 citations
Semantic Scholar
FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma
Li Zhou, M. J. B. Silva, Edward Hsiao, Z. Eroglu +25 more
2025Journal for ImmunoTherapy of Cancer17 citations Open access
Semantic Scholar
Melanoma with osseous or chondroid differentiation: a report of eight cases including SATB2 expression and mutation analysis.
S. Gallagher, T. Bailey, R. Rawson, A. Mahar +4 more
2021Pathology (Sydney)16 citations
Semantic Scholar
Growth hormone secreting pituitary adenoma with admixed gangliocytoma and ganglioglioma.
A. Jukes, R. Allan, R. Rawson, M. Buckland
2016Journal of clinical neuroscience16 citations
Semantic Scholar
In vivo reflectance confocal microscopy can detect the invasive component of lentigo maligna melanoma: Prospective analysis and case–control study
B. Gouveia, G. Carlos, A. Wadell, Christoph Sinz +6 more
2023Journal of the European Academy of Dermatology and Venereology15 citations Open access
Semantic Scholar
Distinct pretreatment innate immune landscape and posttreatment T cell responses underlie immunotherapy-induced colitis
K. Nahar, Felix Marsh-Wakefield, R. Rawson, T. Gide +14 more
2022JCI Insight15 citations Open access
Semantic Scholar
Recurrent bowel obstruction: unusual presentation of pembrolizumab-induced pancreatitis in annular pancreas.
R. Rawson, E. Robbins, R. Kapoor, R. Scolyer +1 more
2017European Journal of Cancer15 citations
Semantic Scholar
LBA39 Personalized combination of neoadjuvant domatinostat, nivolumab (NIVO) and ipilimumab (IPI) in stage IIIB-D melanoma patients (pts) stratified according to the interferon-gamma signature (IFN-γ sign): The DONIMI study
C. Blank, I. Reijers, J. Versluis, A. Menzies +16 more
2021Annals of Oncology14 citations Open access
Semantic Scholar
Improving diagnostic accuracy for suspicious melanocytic skin lesions: New Australian melanoma clinical practice guidelines stress the importance of clinician/pathologist communication.
R. Scolyer, H. Soyer, J. Kelly, C. James +10 more
2019Australian Journal of General Practice14 citations Open access
Semantic Scholar
Germline BAP1 mutations also predispose to cutaneous squamous cell carcinoma.
R. Rawson, G. Watson, A. Maher, S. Mccarthy +2 more
2017Pathology (Sydney)13 citations
Semantic Scholar
Melanomas in children and adolescents: Clinicopathologic features and survival outcomes.
M. El Sharouni, R. Rawson, A. Potter, E. Paver +8 more
2022Journal of American Academy of Dermatology11 citations
Semantic Scholar
Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial.
L. Hoeijmakers, P. Dimitriadis, S. Wijnen, I. Reijers +39 more
2026Nature Medicine10 citations Open access
Semantic Scholar
The progressive relationship between increasing Breslow thickness and decreasing survival is lost in patients with ultra-thick melanomas (≥15mm in thickness).
M. El Sharouni, R. Rawson, V. Sigurdsson, A. Witkamp +5 more
2022Journal of American Academy of Dermatology10 citations Open access
Semantic Scholar
Molecular Profiling of Noncoding Mutations Distinguishes Nevoid Melanomas From Mitotically Active Nevi in Pregnancy
L. Jackett, A. Colebatch, R. Rawson, P. Ferguson +4 more
2019American Journal of Surgical Pathology10 citations
Semantic Scholar
Molecular and clinical correlates of HER3 expression highlights its potential role as a therapeutic target in melanoma.
Eva R. Shteinman, Ismael A. Vergara, R. Rawson, S. Lo +7 more
2023Pathology (Sydney)9 citations Open access
Semantic Scholar
Comprehensive Clinical, Histopathologic, and Molecular Analysis and Long-term Follow-up of Patients With Nodal Blue Nevi
A. Colebatch, C. Adhikari, R. Diefenbach, R. Rawson +7 more
2022American Journal of Surgical Pathology9 citations
Semantic Scholar
Neoadjuvant dabrafenib and trametinib (D+T) for stage III melanoma: Long-term results from the NeoCombi trial.
A. Menzies, R. Saw, S. Lo, Maria Gonzalez +14 more
2022Journal of Clinical Oncology8 citations
Semantic Scholar
Lentigo maligna: defining margins and predictors of recurrence utilizing clinical, dermoscopic, confocal microscopy and histopathology features
P. Star, R. Rawson, M. Drummond, S. Lo +2 more
2021Journal of the European Academy of Dermatology and Venereology8 citations
Semantic Scholar
Pathological response calculation assessment remains accurate with reduced tumor bed examination following neoadjuvant immunotherapy in clinically detectable stage III melanoma.
R. Rawson, N. Maher, A. Menzies, S. Lo +27 more
2025Annals of Oncology7 citations Open access
Semantic Scholar
Benchmarking Survival Outcomes Following Surgical Management of pT3 and pT4 Cutaneous Squamous Cell Carcinoma of the Head and Neck
A. Yung, G. Crouch, A. Varey, S. Lo +7 more
2022Annals of Surgical Oncology7 citations Open access
Semantic Scholar
Mucosal Melanoma: A Review Emphasizing the Molecular Landscape and Implications for Diagnosis and Management.
R. Rawson, J. Wilmott, R. Scolyer
2021Surgical Pathology Clinics7 citations
Semantic Scholar
Longitudinal analysis reveals dynamic changes in histopathologic features in responders to neoadjuvant treatment in a stage III BRAF-mutant melanoma cohort.
Jorja Braden, Alison J. Potter, R. Rawson, N. Adegoke +16 more
2025Modern Pathology6 citations
Semantic Scholar
The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian Cohort
Lisanne P. Zijlker, Henry Chen, A. Spillane, Maria Gonzalez +15 more
2024Annals of Surgical Oncology6 citations Open access
Semantic Scholar
BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting.
R. Scolyer, V. Atkinson, D. Gyorki, D. Lambie +45 more
2021Pathology (Sydney)6 citations
Semantic Scholar
Immunohistochemical investigation of cytokine expression levels as biomarkers in transrectal ultrasound-guided needle biopsy specimens of prostate adenocarcinoma.
Jagtar Singh, Thanuja Thachil, M. Eapen, Aijye Lim +5 more
2021Molecular and clinical oncology6 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Scolyer×34
Invite
R. Scolyer — researcher profile on SciRah
R. Saw×23
Invite
R. Saw — researcher profile on SciRah
J. Wilmott×20
Invite
J. Wilmott — researcher profile on SciRah
G. Long×18
Invite
G. Long — researcher profile on SciRah

×17

Invite

A. Menzies — researcher profile on SciRah

P. Ferguson×16

Invite

P. Ferguson — researcher profile on SciRah

John F. Thompson×15

Invite

John F. Thompson — researcher profile on SciRah

A. Spillane×12

Invite

A. Spillane — researcher profile on SciRah

Invite

S. Lo — researcher profile on SciRah

Invite

R. Scolyer — researcher profile on SciRah

Maria Gonzalez×10

Invite

Maria Gonzalez — researcher profile on SciRah

A. Spillane×10

Invite

A. Spillane — researcher profile on SciRah